Preview

Messenger of ANESTHESIOLOGY AND RESUSCITATION

Advanced search

EXTRACORPOREAL HAEMOCORRECTION AND ITS IMPACT ON FREE-RADICAL OXIDATION AND ANTIOXIDANT DEFENSE IN ABDOMINAL SEPSIS

https://doi.org/10.21292/2078-5658-2018-15-1-40-45

Abstract

Goal: to investigate the impact of extracorporeal haemocorrection on free-radical oxidation and antioxidant defense in those with abdominal sepsis. Subjects and methods. 46 patients were examined. All patients were divided into two groups. Patients from the main group (n = 23) had metabolic support with succinate-containing antioxidants additionally to the standard intensive care and active detoxication (continuous venovenous hemofiltration). Patients from the control group (n = 23) received standard intensive care and active detoxication. The study included five stages: before hemofiltration and in 1 day, 3, 5, and 7 days after its start. Results. It was found out that the investigated rates in the main group differed from the ones in the control group at the last stage of the study, achieving normal values. The significant improvement of the above rates was observed in the control group only at the 5th stage. Conclusion. The combined use of traditional treatment of sepsis, active detoxication and metabolic support with succinate-containing antioxidants results in the faster elimination of oxidative stress, earlier restoration of activity of anti-oxidant protection system and respiratory exchange recovery.

 

About the Authors

V. S. Petrov
Smolensk State Medical University
Russian Federation
Candidate of Medical Sciences, Associate Professor, Senior Researcher pf Research Center, Associate Professor of Anesthesiology and Intensive Care Department with Profession Development Training


M. M. Petrova
Smolensk State Medical University
Russian Federation
Doctor of Medical Sciences, Professor, Head of Anesthesiology and Intensive Care Department with Professional Development Training


S. V. Sviridov
Pirogov Russian National Research Medical University
Russian Federation
Doctor of Medical Sciences, Professor, Head of Anesthesiology and Intensive Care Department


D. V. Surmenev
Smolensk State Medical University
Russian Federation
Researcher of Research Center


References

1. Beloborodov V.B. Immunopathology of severe sepsis and its management. Vestn. Intensivnoy Terapii, 2010, no. 4, pp. 3-8. (In Russ.)

2. Grebenchikov O.А., Zabelina T.S., Filippovskaya Zh.S. et al. Molecular mechanisms of oxidative stress. Vestn. Intensivnoy Terapii, 2016, no. 3, pp. 13-21. (In Russ.)

3. Orlov Yu.P., Dolgikh V.T., Gluschenko А.V. et al. Role of serum iron in the activation of lipid peroxidation in critical states. Obschaya Reanimatologiya, 2006, vol. II, pp. 18-22. (In Russ.)

4. Orlov Yu.P., Ershov А.V., Lukach V.N. et al. Management of free-radical processes and endotoxemia in pancreatonecrosis patients. Khirurgiya. Journal im. N. I. Pirogova, 2015, no. 10, pp. 36-42. (In Russ.)

5. Orlov Yu.P., Lukach V.N., Gluschenko А.V. Reamberin in the intensive care in the patients with severe peritonitis. Novosti Khirurgii. 2013, vol. 21, no. 5, pp. 58-64. (In Russ.)

6. Pasechnik I.N., Skobelev E.I., Krylov V.V. et al. Abdominal sepsis and oxidative stress. Khirurgiya. Journal im. N. I. Pirogova, 2015, no. 12, pp. 18-23. (In Russ.)

7. Rudnov V.А. Sepsis: modern approaches to diagnostics and intensive therapy. Vestn. Anesteziologii I Reanimatologii, 2010, vol. 7, no. 1, pp. 48-57. (In Russ.)

8. Rudnov V.А., Mironov P.I. Clinical recommendation on the management of those with severe sepsis and septic shock (Surviving Sepsis Campaign 2008): analysis and recommendations. Klinicheskaya Mikrobiologiya i Antimikrobnaya Khimioterapiya, 2008, vol. 10, no. 3, pp. 192-201. (In Russ.)

9. Smirnov А.V., Nesterova O.B., Golubev R.V. Succinic acid and its use in the medicine. Part I. Succinic acid: a metabolite and regulator of human metabolism. Nephrologiya, 2014, vol. 18, no. 2, pp. 33-41. (In Russ.)

10. Tolkach А.B., Dolgikh V.T. The impact of reamberin on oxygen balance, oxidative stress and pulmonary dysfunction in the patients with abdominal sepsis. Bulleten' Sibirskoy Meditsiny, 2012, vol. 11, no. 3, pp. 69-75. (In Russ.)

11. Dellinger R.R., Levy M.M., Rhodes A. et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit. Care Med., 2013, vol. 41, pp. 580-637.

12. Laupland K.B., Kirkpatrick A.W., Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically III adults: a systematic review and meta-analysis. Crit. Care Med., 2007, vol. 35, no. 12, pp. 2686-2692.

13. Turgeon A.F., Hutton B., Fergusson D.A. et al. Metaanalysis: Intravenous immunoglobulin in critically ill adult patients with sepsis. Ann. Intern. Med., 2007, vol. 146, pp. 193-203.

14. Victor V.M., Espulgues J.V., Hernandez-Mijares A., Rocha M. Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants. Infec. CDisord Drug. Targets, 2009, vol. 9. pp. 376-389.


Review

For citations:


Petrov V.S., Petrova M.M., Sviridov S.V., Surmenev D.V. EXTRACORPOREAL HAEMOCORRECTION AND ITS IMPACT ON FREE-RADICAL OXIDATION AND ANTIOXIDANT DEFENSE IN ABDOMINAL SEPSIS. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2018;15(1):40-45. (In Russ.) https://doi.org/10.21292/2078-5658-2018-15-1-40-45



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2078-5658 (Print)
ISSN 2541-8653 (Online)